Venom’s analytics team has published a fresh ranking of the world’s largest blockchains, but this one skips market-cap gymnastics and looks at what really matters for adoption: daily active users. The new study ranks networks by DAU as of mid-January 2026, arguing that daily activity is the clearest signal of real-world usage rather than speculative value. For readers who want the full breakdown and methodology, the report is available here.
The headline numbers make the point plainly. BNB Chain leads the pack with roughly 4.1 million daily active users, followed by Solana at about 2.7 million and Tron with 2.5 million DAU. Those three sit well ahead of the rest, powered by ultra-low fees, fast execution, and explosive retail use cases such as DeFi apps, meme-coin trading and stablecoin transfers that consistently bring millions of wallets on-chain each day.
Below that front line is a second tier of networks that, while smaller on raw retail traffic, are positioning themselves as the backbone for institutional and enterprise use. Aptos registers roughly 1.4 million DAU, Ethereum’s mainnet sits near 650,000, and the list continues with Venom (90,000), Sui (85,000), TON (75,600) and Avalanche (56,400). The report frames this split as a market stratification: some chains chase mass retail adoption through accessibility and viral products, while others build for regulated, high-throughput business cases.
Venom Foundation, the Abu Dhabi-based blockchain developer behind the study, is itself an interesting case study in that second camp. The foundation has deliberately positioned Venom as infrastructure for governments and large financial institutions rather than a retail playground.
“We’re not competing for retail meme coin users,” comments Christopher Louis Tsu, CEO of Venom Foundation. “Our target audience is central banks, sovereign wealth funds, and financial institutions that need infrastructure with 100,000+ transactions per second throughput, sub-second finality, and full regulatory compliance.”
That focus helps explain why Venom’s DAU sits well below the mass-market leaders but still earns a place in a top-10 list judged by real usage. The full study includes a short analysis explaining how different DAU profiles map to distinct go-to-market strategies.
On the performance front, Venom has been public about its engineering targets and milestones. The network’s hybrid Layer-0/Layer-1 architecture, which uses Mesh technology and dynamic sharding, reportedly sustained a closed-network stress test of 150,000 transactions per second in May 2025, and the team has publicly stated plans to push toward 200,000 TPS by the end of the year.
It is a capability the company argues is essential for national payment systems, CBDCs and high-frequency tokenized-asset trading. Multiple industry outlets covered the May stress test and Venom’s roadmap. Venom’s pitch goes further than raw speed. The foundation casts the network as a compliance-friendly platform designed to host regulated stablecoins, real-world asset tokenization and central-bank digital currency pilots.
That narrative has been reinforced by product moves and funding initiatives aimed at enterprise adoption, including grants and partnerships to accelerate use cases that require both throughput and auditability. Coverage of these initiatives has noted Venom’s emphasis on uptime, low fees and enterprise tooling as selling points for institutional clients.
The broader finding from Venom’s ranking is simple but meaningful for 2026: blockchain markets are not a single, converging race. Instead, they look like layered markets where a handful of chains capture huge retail audiences with low friction and viral products, and a different set of platforms compete on reliability, compliance and raw performance for banks, exchanges and governments.
Both strategies are viable today, but they serve different customers and will likely shape which networks lead in transactions, custody solutions, and real-world deployments over the next several years. For readers who want to dive into the full top-10 list and the study’s methodology, Venom’s PDF is available on this page.

